ArticleBlood2019

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.

Jonas Samuel Jutzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.